Hi Trader,
Dividend investors wait months for tiny payouts… often just a few percent per year.
But what if you could create your own “dividends” every single week — without tying up huge amounts of capital?
That’s exactly what this method is designed to do.
It’s like turning ordinary stocks into income engines — not once a quarter, but week after week.
Discover how to create your own weekly dividend →
Preston James
Wall Street Loves FIGS. So Why Do Price Targets Predict a Pullback?
Written by Jennifer Woods. Date Posted: 3/2/2026.
After a stunning plunge following its 2021 IPO, medical and lifestyle apparel company FIGS, Inc. (NYSE: FIGS) has roared back to a price it hasn't touched in nearly four years. The stock has surged almost 260% over the past year, including a 58% jump in the last month alone. The rally has been fueled by strong earnings reports and a wave of bullish analyst commentary. Yet despite the rally and positive sentiment, the consensus 12-month price target sits at just $12.25 — almost 30% below the current stock price. That raises the question: how much of this recovery is supported by fundamentals, and how much is momentum? A closer look at FIGS' recent earnings and the stock's price movement offers some clues.
Early investors in FIGS saw a quick windfall after the company's IPO, which debuted in May 2021 at $22 per share and, within a month, surged to $50. It was a strong moment for medical apparel companies, as the COVID-19 pandemic had spurred demand for such gear. However, as the pandemic eased, shares sharply reversed course and, within 12 months, were trading below $8. In the years that followed, FIGS remained mostly range-bound in the single digits, though after dipping below $4 in April 2025, the stock began another climb — this time to the upside.
Earnings Momentum Sparks Rally
After steady gains following positive Q1 and Q2 2025 earnings, the Q3 2025 results, released on Nov. 6, sent the stock higher. The report showed stronger-than-expected revenue growth, solid demand across its core business, and healthy margins despite tariff pressures. The company also issued an upbeat outlook, raising its full-year guidance for net revenue and adjusted EBITDA margins. Wall Street applauded, driving the stock up more than 30% over the following week and prompting Zacks Research to upgrade the rating to Strong Buy from Hold.
Elon Musk: This Could Turn $100 into $100,000 (Ad)
What if you could shrink your entire wealth journey from decades down to just 24 hours?
Sounds impossible…
But I'll show you how Elon Musk is about to make it a reality.
Key Points
- FIGS stock is up nearly 260% over the last year
- Strong earnings have fueled the rally
- Stock is trading almost 30% above the average price target
- Special Report: [Sponsorship-Ad-6-Format3]
The momentum continued after the recent Q4 2025 earnings report on Feb. 26. The report highlighted a 33% jump in revenue and marked the company's best quarterly revenue, with sales topping $200 million. On the earnings call, the company — which earned some bragging rights by outfitting Team USA's medical team at the Winter Olympics — pointed to strength across the board, including growth in its active customer base and higher average order values. Scrubwear, FIGS' core product, was a standout: sales, which accounted for more than three-quarters of net revenue, rose 35%. International sales also helped drive growth, rising 55%.
The fourth quarter capped off a strong year for FIGS, as net revenue rose 14% year-over-year to a record $630 million. Despite tariff pressures that pressured gross margins, profitability remained solid, with full-year adjusted EBITDA margin beating its target by more than 200 basis points.
Earnings And Outlook Spark Analyst Support
FIGS also issued an upbeat outlook for the year ahead, expecting continued strong demand helped by growth in healthcare jobs. The company highlighted plans to expand into new international markets, prioritize growth opportunities across its businesses, and continue its stock buyback program. For fiscal 2026, FIGS expects net revenue to grow 10% to 12%, with improving profitability targets.
Analysts were similarly upbeat after the earnings release. Barclays raised its rating to Strong Buy from Hold; KeyCorp shifted to Overweight from Sector Weight with a $17 price target; and Goldman Sachs moved its rating to Hold from Strong Sell. BTIG reiterated a Buy rating with a $15 target, and Telsey Advisory bumped its target to $15 from $9.
FIGS Stock Pushes Past Price Targets
FIGS' strong earnings have been the clear driver behind the stock's push to four-year highs. Shares began climbing even before the Q4 report, jumping nearly 14% in the session ahead of the release. After the results were announced, the rally intensified: the stock surged 24% on the first trading day following the report, then added another 10% the next day. As of March 4, the stock was trading above $17 — almost 30% above the average 12-month price target of $12.25 based on 10 analyst reports. It's more than double Morgan Stanley's $8 target issued in January and sits at the high end alongside KeyCorp's $17 target.
The gap between broadly bullish analyst commentary and relatively low price targets suggests analysts like FIGS' improving fundamentals but remain cautious about valuation. At its current level, shares trade at a price-to-earnings ratio near 90, implying much of FIGS' expected growth may already be priced in. Investors are clearly applauding the company's turnaround, but skepticism remains about whether the stock can continue rising from here or if a pullback is likely.
2 Bad News Buys: Why Palo Alto and Zscaler Are Screaming Deals
Written by Thomas Hughes. Date Posted: 3/2/2026.
Key Points
- Palo Alto Networks and Zscaler have sold off sharply from their peaks, pushing technicals and valuations to levels that historically foreshadow rebounds.
- Both companies lead cybersecurity with unified, platform-based approaches that deliver industry-leading margins and above-sector revenue growth.
- Institutional buying has overtaken selling since late 2025, and short-covering is underway in both stocks.
- Special Report: [Sponsorship-Ad-6-Format3]
Down as much as 55% from peak to trough and more than 20% in 2026, it may be time to buy cybersecurity stocks like Palo Alto Networks (NASDAQ: PANW) and Zscaler (NASDAQ: ZS). While valuation concerns have plagued — and may continue to plague — these names, their share prices are trading near long-term lows and appear unlikely to fall significantly further.
Not only are their growth trajectories robust, but long-term forecasts likely underestimate their strengths in a world driven by accelerating digitization, deeper penetration of digital services, regulatory requirements, and AI. While AI drives efficiency, automation, and better outcomes for businesses, it is also improving capabilities for cybercriminals.
Elon Musk: This Could Turn $100 into $100,000 (Ad)
What if you could shrink your entire wealth journey from decades down to just 24 hours?
Sounds impossible…
But I'll show you how Elon Musk is about to make it a reality.
Palo Alto Networks and Zscaler are well-positioned within the industry. Their unified approaches provide comprehensive security in a highly fragmented market. They enable vendor reduction, superior performance, enhanced threat detection, prevention, mitigation, and recovery, as well as improved scale and margins.
They deliver industry-leading gross and profit margins, with gross margins in the 70% to 80% range versus legacy, hardware-based providers. Palo Alto, specifically, offers more than 20 products across cloud, networking, and systems security, while Zscaler is widely regarded as the leader in cloud-native, zero-trust architecture.
Oversold and Ready to Rebound, Palo Alto Networks and Zscaler Are Being Accumulated
The charts reflect oversold conditions and a strong capacity to rebound. The monthly charts highlight the ultra-long-term secular trends and show both names at or near long-term lows, with stochastic oscillators in low ranges near historical troughs — a pattern that often precedes a rebound. Price action on these charts also shows technical support, as do other indicators.
The weekly charts tell a similar story: markets are at least oversold. Zscaler's stochastic has flatlined at extreme lows for several months while the moving-average convergence-divergence (MACD) shows a slight divergence. That divergence suggests bears are losing their grip and bulls are beginning to reassert themselves. Both Zscaler and Palo Alto have seen increased trading volume, indicating buying interest at these low levels.
Daily charts are also constructive when viewed alongside the monthly and weekly signals. They indicate the markets have at least reached a bottom, if not absolute lows, and suggest potential for a rebound. These signals coincide with prior support and resistance levels, strengthening the case. The indicators are aligned and poised to trigger a strong buy signal if price action advances again. If that happens, the lows currently in play will be confirmed and market reversals will become higher-probability outcomes.
Valuation, Analyst Sentiment, and Institutional Activity Point to a Cybersecurity Rebound
Valuations remain elevated, with PANW trading near 40X its current-year earnings outlook and Zscaler near 36X, but those multiples price in robust growth expectations.
The cybersecurity industry is expected to grow at a 10% to 15% compound annual growth rate (CAGR) over the next decade, while leaders such as Palo Alto and Zscaler are forecast to outpace that growth.
Palo Alto, the larger of the two, is forecast to grow at a high-teens CAGR and Zscaler at a low-to-mid 20% CAGR, which places both in attractive value territory relative to the 2035 consensus.
On that basis, these stocks would trade at only roughly 12X and 8X their long-term forecasts, implying about 100% upside for PANW and nearly 200% for Zscaler just to align with broad market averages as they grow into those forecasts. If they continue to command a market premium, upside could be greater.
Analysts contributed to the 2025–2026 price corrections by collectively trimming price targets, which pushed both names toward the low end of target ranges.
As of early March 2026, however, the corrections look overblown and opportunity is emerging. Zscaler trades well below the low end of its target range, with consensus suggesting potential for an 85% upside; Palo Alto sits nearer the low end of its range, with consensus forecasting about 40% upside.
Institutional activity also supports the case for a bottom. Institutions sold heavily in Q3 2025, pressuring prices, but reverted to buying in Q4 and early Q1 2026.
MarketBeat's data show institutions have been accumulating at a pace of more than $2 bought for every $1 sold, providing solid support and a potential tailwind once rebounds gain momentum. Short interest is notable as well: MarketBeat's data indicate short-covering is underway in both names.
This email content is a sponsored message for Traders Edge Network, a third-party advertiser of MarketBeat. Why did I receive this email?.
If you have questions about your account, please feel free to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103. USA..